Polysaccharides-modified Nanoparticle Production Service
Overview of Polysaccharides-modified Nanoparticles
Polysaccharides-modified nanoparticles are engineered using natural polysaccharides, offering exceptional biocompatibility, biodegradability, and low toxicity. These nanoparticles are widely applied in drug delivery, tissue engineering, diagnostic imaging, and sustainable industrial processes. Their ability to encapsulate bioactive substances, target specific tissues, and enhance stability makes them versatile tools in various fields. Synthesis Methods include ionic/covalent crosslinking, self-assembly, and polyelectrolyte complexation, enabling controlled size and morphology.
Fig.1 Overview of polysaccharide NP formation and their applications. (Plucinski, et al., 2021)
Our GlycoNano™ Platform offers advanced Glyconanoparticle Development Services and Carbohydrate-based Nanoparticle Production Services. By integrating carbohydrates into nanoparticle structures, our systems are not only biocompatible and biodegradable but also capable of selectively targeting specific cells and tissues.
Fig.2 Chemical structures of polysaccharides. (Plucinski, et al., 2021)
CD BioGlyco offers an extensive polysaccharides-modified nanoparticles production service through our GlycoNano™ Platform, catering to diverse research and industrial needs. These services include customized solutions, such as pH-sensitive Ganoderma polysaccharide nanoparticles, cholesterol-modified pullulan nanoparticles, and dextran-polyacrylic acid nanoparticles, ensuring tailored approaches to meet specific scientific challenges.
| Ganoderma Polysaccharides-modified Bismuth Sulfide Nanoparticle Production | ||
| ASP-PLGA NPs Production | ||
| Acetylsalicylic Acid/Aminoglycan Complex Nanoparticle Production | ||
| Stearic Acid-modified Pullulan Polysaccharide Nanoparticle Production | ||
| Fucoidan Self-Assembly Nanoparticle Production | ||
| Cholesterol-modified Pullulan Polysaccharide Self-Assembled Nanoparticle Production | ||
| Ganoderma Lucidum Polysaccharide-histidine Conugated pH-Sensitive Nanoparticle Production | ||
| pH/Redox Response of Ganoderma Lucidum Polysaccharide Conjugated Nanoparticle Production | ||
| pH-Responsive Ganoderma Polysaccharides-Phenylborate-Methotrexate Conjugated Nanoparticle Production | ||
| Alginate-modified Nanoparticle Production | ||
| Modified Sodium Alginate Activated SiO2 Nanoparticles | Alginate Nanoparticles | Galactose-modified Alginate Nanoparticles (Dox/Ha-Gal) |
| Biparental Hydroxypropyl-β-Cyclodextrin Nanoparticles | ||
| Chitosan-modified Glyconanoparticle Production | ||
| Chitosan conjugated Ovalbumin Nanoparticles (Ova-Chitosan) | Methyl Chitosan Nanoparticles | Carboxymethyl Chitosan Nanoparticles |
| Novel Chitosan Grafted Copolymer Nanoparticles | Amphiphilic Fluralin/Carboxymethyl Chitosan Nanoparticles | Water-Soluble Chitosan Nanoparticles |
| Salicylate Chitosan Nanoparticles | Chitosan Fluorescent Nanoparticles | Chitosan-Phospholipid Self-Assembly Nanoparticles |
| Folic Acid Conjugates Chitosan Nanoparticles | Bsa Loading Properties of Water-Soluble Chitosan Nanoparticles | Emodin/Berberine-Chitosan Double Nanoparticles |
| Oleanolic Acid Grafted onto Chitosan Nanoparticles | Pegyl-Chitosan-Curcumin Polymer-Nanoparticles | Glycyrrhizate-modified Chitosan/Carboxylated Chitosan Composite Nanoparticles |
| Chitosan Nanoparticles-modified By Quaternary Amine Salt | Self-Assembled Chitosan Nanoparticles | Chitosan Grafted Copolymer Nanoparticles |
| Temperature Sensitive Chitosan Based Polyelectrolyte Nanoparticles | Cholesterylated Chitosan Nanocarriers | Glycyrrhetinic Acid-modified Chitosan Nanoparticles |
| Hydrophobic Modification of Magnetic Chitosan Nanoparticles | Chitosan A Mesoporous Silica Nanoparticles | Trimethylated Chitosan Oobumin Nanoparticles |
| Chitosan Grafted Polymer Nanoparticles | Chitosan-mesoporous Siica Nanoparticles | |
| Dextran-polyacrylic Acid Nanoparticle Production | ||
| Hyaluronic Acid-modified Nanoparticle Production | ||
| Hyaluronic Acid-modified Dexamethasone Core-Shell Nanoparticles | Hyaluronic Acid-modified Prussian Blue Nanoparticles | Hyaluronic Acid Nanoparticle Polyelectrolyte Complex |
| Hyaluronic Acid-modified pH-Sensitive Core-Shell Nanoparticles | Hyaluronic Acid-modified Albumin Nanoparticles | |
Quality Analysis
To ensure the reliability and performance of polysaccharides-modified nanoparticles, several analytical methods are used.
Dynamic Light Scattering
Measures particle size and size distribution.
Transmission Electron Microscopy
Analyzes morphology and surface structure.
Zeta Potential Analysis
Assesses surface charge and stability.
High-Performance Liquid Chromatography
Evaluates drug encapsulation and release profiles.
Fourier Transform Infrared Spectroscopy
Confirms chemical modifications.
Characterization of Glyconanoparticle
Applications
- Biomedical: Polysaccharides-modified nanoparticles can be used for the research of targeted drug delivery, imaging, and tissue engineering.
- Cosmetic and Food: Polysaccharides-modified nanoparticles can be used as stabilizers in emulsions and carriers for bioactive compounds.
- Agriculture: Polysaccharides-modified nanoparticles can be used for nanosensors, nanopesticides, and smart packaging.
Advantages
- High drug-loading efficiency.
- Biocompatibility and low toxicity.
- Targeted functionality for specific tissues.
- Sustainable production from abundant natural resources.
Frequently Asked Questions
- What services are included in the polysaccharides-modified nanoparticle production service at CD BioGlyco?
CD BioGlyco offers a wide range of services under the polysaccharides-modified nanoparticle production service, including Ganoderma polysaccharides-modified bismuth sulfide nanoparticles, chitosan-modified nanoparticles, hyaluronic acid-modified nanoparticles, and alginate-modified nanoparticles. - How are polysaccharides-modified nanoparticles characterized at CD BioGlyco?
Our characterization services include physicochemical property analysis using techniques like FTIR, XPS, NMR, and TGA, as well as molecular interaction analysis for studying carbohydrate interactions with proteins, lipids, nucleic acids, and other biomolecules.
Publication
Technology: Scanning electron microscopy, Transmission electron microscopy, Atomic force microscopy, Nanoparticle tracking analysis, Dynamic light scattering, Fourier transform infrared spectroscopy, X-ray diffraction
Journal: Journal of Materials Chemistry B
IF: 6.1
Published: 2021
Results: This review delves into the world of polysaccharide nanoparticles (polysaccharide NPs), emphasizing their unique properties like biocompatibility, biodegradability, renewable origin, and easy modification, making them ideal building blocks for NP fabrication. It introduces various common polysaccharides such as chitosan, cellulose, starch, hyaluronic acid, dextran, pullulan, alginate, and carrageenan, discussing their properties and applications in NP formation. It also explores multiple strategies for synthesizing polysaccharide NPs, including nanoprecipitation, complex coacervation, emulsion-based methods, and other techniques like desolvation, dialysis, ionic gelation, and spray drying.
Fig.3 Avenues for the preparation of polysaccharide NPs. (Plucinski, et al., 2021)
At CD BioGlyco, we use advanced techniques such as ionic crosslinking, covalent modification, and self-assembly, we produce nanoparticles with exceptional biocompatibility, stability, and targeting capabilities. Our offerings include specialized products like Ganoderma polysaccharides-modified bismuth sulfide nanoparticles, chitosan-modified nanoparticles, and hyaluronic acid-modified nanoparticles. Contact us today to explore how our polysaccharides-modified nanoparticlecan help advance your research.
Reference
- Plucinski, A.; et al. Polysaccharide nanoparticles: From fabrication to applications. Journal of Materials Chemistry B. 2021, 9(35): 7030-7062.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform






